# Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir

> **NCT06399926** · — · RECRUITING · sponsor: **Xiangya Hospital of Central South University** · enrollment: 64 (estimated)

## Conditions studied

- Leptomeningeal Metastasis
- Lung Cancer

## Interventions

- **DRUG:** Pemetrexed injection
- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT06399926
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2024-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06399926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06399926, "Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06399926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*